Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Charlotte Sorieul, Marta Dolce, Maria Rosaria Romano, Jeroen Codée & Roberto Adamo. (2023) Glycoconjugate vaccines against antimicrobial resistant pathogens. Expert Review of Vaccines 22:1, pages 1055-1078.
Read now
Read now
Alessandra Ferraro, Sofia M. Buonocore, Philippe Auquier, Isabelle Nicolas, Hugues Wallemacq, Dominique Boutriau & Robbert G. van der Most. (2019) Role and plasticity of Th1 and Th17 responses in immunity to Staphylococcus aureus. Human Vaccines & Immunotherapeutics 15:12, pages 2980-2992.
Read now
Read now
Jan T. Poolman & Annaliesa S. Anderson. (2018) Escherichia coli and Staphylococcus aureus: leading bacterial pathogens of healthcare associated infections and bacteremia in older-age populations. Expert Review of Vaccines 17:7, pages 607-618.
Read now
Read now
Bo Liu, Saeyoung Park, Christopher D. Thompson, Xue Li & Jean C. Lee. (2017) Antibodies to Staphylococcus aureus capsular polysaccharides 5 and 8 perform similarly in vitro but are functionally distinct in vivo. Virulence 8:6, pages 859-874.
Read now
Read now
Michael L. Landrum, Tahaniyat Lalani, Minoo Niknian, Jason D. Maguire, Duane R. Hospenthal, Ali Fattom, Kimberly Taylor, Jamie Fraser, Kenneth Wilkins, Michael W. Ellis, Paul D. Kessler, Rafaat E. F. Fahim & David R. Tribble. (2017) Safety and immunogenicity of a recombinant Staphylococcus aureus α-toxoid and a recombinant Panton-Valentine leukocidin subunit, in healthy adults. Human Vaccines & Immunotherapeutics 13:4, pages 791-801.
Read now
Read now
Gustavo H. Dayan, Naglaa Mohamed, Ingrid L. Scully, David Cooper, Elizabeth Begier, Joseph Eiden, Kathrin U. Jansen, Alejandra Gurtman & Annaliesa S. Anderson. (2016) Staphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention. Expert Review of Vaccines 15:11, pages 1373-1392.
Read now
Read now
Articles from other publishers (40)
Pooi Yin Chung. (2023)
Immunotherapies for the prevention and treatment of
Staphylococcus aureus
infections: updates and challenges
. Pathogens and Disease 81.
Crossref
Crossref
Nimat Ullah, Farha Anwer, Zaara Ishaq, Abubakar Siddique, Majid Ali Shah, Moazur Rahman, Abdur Rahman, Xinrui Mao, TingTing Jiang, Bok Luel Lee, Taeok Bae & Amjad Ali. (2022) In silico designed Staphylococcus aureus B-cell multi-epitope vaccine did not elicit antibodies against target antigens suggesting multi-domain approach. Journal of Immunological Methods 504, pages 113264.
Crossref
Crossref
Hamid Reza Jahantigh, Sobhan Faezi, Mehri Habibi, Mehdi Mahdavi, Angela Stufano, Piero Lovreglio & Khadijeh Ahmadi. (2022) The Candidate Antigens to Achieving an Effective Vaccine against Staphylococcus aureus. Vaccines 10:2, pages 199.
Crossref
Crossref
Giuseppe Stefanetti, Francesco Borriello, Barbara Richichi, Ivan Zanoni & Luigi Lay. (2022) Immunobiology of Carbohydrates: Implications for Novel Vaccine and Adjuvant Design Against Infectious Diseases. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Birgit Weinberger. 2022. Healthy Longevity and Immune System. Healthy Longevity and Immune System
119
164
.
Jonwei Hwang, Alyssa Thompson, Joanna Jaros, Paul Blackcloud, Jennifer Hsiao & Vivian Y. Shi. (2021)
Updated understanding of
Staphylococcus aureus
in atopic dermatitis: From virulence factors to commensals and clonal complexes
. Experimental Dermatology 30:10, pages 1532-1545.
Crossref
Crossref
Rahul Chatterjee, Panchanan Sahoo, Soumya Ranjan Mahapatra, Jyotirmayee Dey, Mrinmoy Ghosh, Gajraj Singh Kushwaha, Namrata Misra, Mrutyunjay Suar, Vishakha Raina & Young-Ok Son. (2021) Development of a Conserved Chimeric Vaccine for Induction of Strong Immune Response against Staphylococcus aureus Using Immunoinformatics Approaches. Vaccines 9:9, pages 1038.
Crossref
Crossref
Jonah Clegg, Elisabetta Soldaini, Rachel M. McLoughlin, Stephen Rittenhouse, Fabio Bagnoli & Sanjay Phogat. (2021) Staphylococcus aureus Vaccine Research and Development: The Past, Present and Future, Including Novel Therapeutic Strategies. Frontiers in Immunology 12.
Crossref
Crossref
Arundhathi Venkatasubramaniam, Grant Liao, Eunice Cho, Rajan P. Adhikari, Tom Kort, Frederick W. Holtsberg, Karen E. Elsass, Dean J. Kobs, Thomas L. RudgeJrJr, Keith D. Kauffman, Nickiana E. Lora, Daniel L. Barber, M. Javad Aman & Hatice Karauzum. (2021) Safety and Immunogenicity of a 4-Component Toxoid-Based Staphylococcus aureus Vaccine in Rhesus Macaques. Frontiers in Immunology 12.
Crossref
Crossref
Ingrid L. Scully, Yekaterina Timofeyeva, Arthur Illenberger, Peimin Lu, Paul A. Liberator, Kathrin U. Jansen & Annaliesa S. Anderson. (2021) Performance of a Four-Antigen Staphylococcus aureus Vaccine in Preclinical Models of Invasive S. aureus Disease. Microorganisms 9:1, pages 177.
Crossref
Crossref
Mustafa Khasraw, David A. Reardon, Michael Weller & John H. Sampson. (2020) PD-1 Inhibitors: Do they have a Future in the Treatment of Glioblastoma?. Clinical Cancer Research 26:20, pages 5287-5296.
Crossref
Crossref
Raziey Parastan, Mohammad Kargar, Kavous Solhjoo & Farshid Kafilzadeh. (2020) Staphylococcus aureus biofilms: Structures, antibiotic resistance, inhibition, and vaccines. Gene Reports 20, pages 100739.
Crossref
Crossref
Jonwei Hwang, Joanna Jaros & Vivian Y. Shi. (2020) Staphylococcus aureus in Atopic Dermatitis: Past, Present, and Future. Dermatitis 31:4, pages 247-258.
Crossref
Crossref
Hao Zeng, Feng Yang, Qiang Feng, Jinyong Zhang, Jiang Gu, Haiming Jing, Changzhi Cai, Liming Xu, Xi Yang, Xin Xia, Ni Zeng, Shaowen Fan & Quanming Zou. (2020) Rapid and Broad Immune Efficacy of a Recombinant Five-Antigen Vaccine against Staphylococcus aureus Infection in Animal Models. Vaccines 8:1, pages 134.
Crossref
Crossref
C Buddy Creech, Robert W Frenck, Anne Fiquet, Robert Feldman, Martin K Kankam, Sudam Pathirana, James Baber, David Radley, David Cooper, Joseph Eiden, William C Gruber, Kathrin U Jansen, Annaliesa S Anderson & Alejandra Gurtman. (2020) Persistence of Immune Responses Through 36 Months in Healthy Adults After Vaccination With a Novel Staphylococcus aureus 4-Antigen Vaccine (SA4Ag). Open Forum Infectious Diseases 7:1.
Crossref
Crossref
Timothy J. Foster. 2019. Gram-Positive Pathogens. Gram-Positive Pathogens
599
617
.
Paul J. Planet, Dane Parker, Naomi L. Ruff & Henry R. Shinefield. (2019) Revisiting Bacterial Interference in the Age of Methicillin-resistant Staphylococcus aureus. Pediatric Infectious Disease Journal 38:9, pages 958-966.
Crossref
Crossref
Timothy J. Foster. (2019)
Surface Proteins of
Staphylococcus aureus
. Microbiology Spectrum 7:4.
Crossref
Crossref
Eóin C. O’Brien & Rachel M. McLoughlin. (2019) Considering the ‘Alternatives’ for Next-Generation Anti-Staphylococcus aureus Vaccine Development. Trends in Molecular Medicine 25:3, pages 171-184.
Crossref
Crossref
Roisin Connolly, Mark D. Denton, Hilary Humphreys & Rachel M. McLoughlin. (2019) Would hemodialysis patients benefit from a Staphylococcus aureus vaccine?. Kidney International 95:3, pages 518-525.
Crossref
Crossref
Fabio Rigat, Erika Bartolini, Mattia Dalsass, Neha Kumar, Sara Marchi, Pietro Speziale, Domenico Maione, Luqiu Chen, Maria Rosaria Romano, Maria-Luisa Alegre, Fabio Bagnoli, Robert S. Daum & Michael Z. David. (2019) Retrospective Identification of a Broad IgG Repertoire Differentiating Patients With S. aureus Skin and Soft Tissue Infections From Controls. Frontiers in Immunology 10.
Crossref
Crossref
Peyman Avakh Majelan, Mehdi Mahdavi, Mohammad Hossein Yazdi, Elaheh Salimi & Mohammad Reza Pourmand. (2019) Recombinant Staphylococcal Antigen-F (r-ScaF), a novel vaccine candidate against methicillin resistant Staphylococcus aureus infection: Potency and efficacy studies. Microbial Pathogenesis 127, pages 159-165.
Crossref
Crossref
William Jiranek, James W.M. Kigera, Brian A. Klatt, Fatih Küçükdurmaz, Jay Lieberman, Claus Moser, Kevin Mulhall, Hasan Nahouli, Edward Schwarz, Noam Shohat & Majd Tarabichi. (2019) General Assembly, Prevention, Host Risk Mitigation - General Factors: Proceedings of International Consensus on Orthopedic Infections. The Journal of Arthroplasty 34:2, pages S43-S48.
Crossref
Crossref
Julianne Clowry, Alan D. Irvine & Rachel M. McLoughlin. (2019) Next-generation anti–Staphylococcus aureus vaccines: A potential new therapeutic option for atopic dermatitis?. Journal of Allergy and Clinical Immunology 143:1, pages 78-81.
Crossref
Crossref
Karan Goswami & Javad Parvizi. 2019. Targeting Biofilms in Translational Research, Device Development, and Industrial Sectors. Targeting Biofilms in Translational Research, Device Development, and Industrial Sectors
71
83
.
Christopher D. Dupont, Ingrid L. Scully, Ross M. Zimnisky, Brinda Monian, Christina P. Rossitto, Ellen B. O'Connell, Kathrin U. Jansen, Annaliesa S. Anderson & J. Christopher Love. (2018)
Two Vaccines for
Staphylococcus aureus
Induce a B-Cell-Mediated Immune Response
. mSphere 3:4.
Crossref
Crossref
Francesca Micoli, Paolo Costantino & Roberto Adamo. (2018) Potential targets for next generation antimicrobial glycoconjugate vaccines. FEMS Microbiology Reviews 42:3, pages 388-423.
Crossref
Crossref
Stephen P. Lockhart, Daniel A. Scott, Kathrin U. Jansen, Annaliesa S. Anderson & William C. Gruber. 2018. Carbohydrate-Based Vaccines: From Concept to Clinic. Carbohydrate-Based Vaccines: From Concept to Clinic
7
59
.
Keenan A. Lacey, John M. Leech, Stephen J. Lalor, Niamh McCormack, Joan A. Geoghegan & Rachel M. McLoughlin. (2017) The Staphylococcus aureus Cell Wall-Anchored Protein Clumping Factor A Is an Important T Cell Antigen. Infection and Immunity 85:12.
Crossref
Crossref
N Mohamed, M Y Wang, J-C Le Huec, U Liljenqvist, I L Scully, J Baber, E Begier, K U Jansen, A Gurtman & A S Anderson. (2017)
Vaccine development to prevent
Staphylococcus aureus
surgical-site infections
. British Journal of Surgery 104:2, pages e41-e54.
Crossref
Crossref
Mathias W. Pletz, Julia Uebele, Karen Götz, Stefan Hagel & Isabelle Bekeredjian-Ding. (2016) Vaccines against major ICU pathogens. Current Opinion in Critical Care 22:5, pages 470-476.
Crossref
Crossref
Cecilia Buonsanti, Cristiana Balocchi, Carole Harfouche, Federica Corrente, Luisa Galli Stampino, Francesca Mancini, Marta Tontini, Padma Malyala, Simone Bufali, Barbara Baudner, Ennio De Gregorio, Nicholas M. Valiante, Derek T. O’Hagan, Rino Rappuoli & Ugo D’Oro. (2016) Novel adjuvant Alum-TLR7 significantly potentiates immune response to glycoconjugate vaccines. Scientific Reports 6:1.
Crossref
Crossref
Annemarie Kuipers, Daphne A. C. Stapels, Lleroy T. Weerwind, Ya-Ping Ko, Maartje Ruyken, Jean C. Lee, Kok P. M. van Kessel & Suzan H. M. Rooijakkers. (2016) The Staphylococcus
aureus polysaccharide capsule and Efb-dependent fibrinogen shield act in concert to protect against phagocytosis. Microbiology 162:7, pages 1185-1194.
Crossref
Crossref
Birgitte K. Giersing, Sana S. Dastgheyb, Kayvon Modjarrad & Vasee Moorthy. (2016) Status of vaccine research and development of vaccines for Staphylococcus aureus. Vaccine 34:26, pages 2962-2966.
Crossref
Crossref
Annaliesa S. Anderson, Ingrid L. Scully, Ed T. Buurman, Joseph Eiden & Kathrin U. Jansen. (2016) Staphylococcus aureus Clumping Factor A Remains a Viable Vaccine Target for Prevention of S. aureus Infection. mBio 7:2.
Crossref
Crossref
Barbara Bröker, Daniel Mrochen & Vincent Péton. (2016) The T Cell Response to Staphylococcus aureus. Pathogens 5:1, pages 31.
Crossref
Crossref
Xue Li, Xiaogang Wang, Christopher D. Thompson, Saeyoung Park, Wan Beom Park & Jean C. Lee. (2016) Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection. mBio 7:1.
Crossref
Crossref
Clarissa Pozzi, Reuben Olaniyi, Lassi Liljeroos, Ilaria Galgani, Rino Rappuoli & Fabio Bagnoli. 2017. Staphylococcus aureus. Staphylococcus aureus
491
528
.
Ingrid L Scully, Kena Swanson, Luke Green, Kathrin U Jansen & Annaliesa S Anderson. (2015) Anti-infective vaccination in the 21st century—new horizons for personal and public health. Current Opinion in Microbiology 27, pages 96-102.
Crossref
Crossref
Christopher Weidenmaier & Jean C. Lee. 2017. Staphylococcus aureus. Staphylococcus aureus
57
93
.